<!--
 Copyright Duke Comprehensive Cancer Center and SemanticBits
 
 Distributed under the OSI-approved BSD 3-Clause License.
 See https://github.com/NCIP/c3pr/blob/gh-pages/LICENSE.txt for details.
-->
<ns1:caXchangeResponseMessage xmlns:ns1="http://caXchange.nci.nih.gov/messaging">
 <ns1:responseMetadata>
  <ns1:externalIdentifier>extId</ns1:externalIdentifier>
  <ns1:caXchangeIdentifier>97ffc190-9d57-11de-bc0e-b41a9e479bc8</ns1:caXchangeIdentifier>
 </ns1:responseMetadata>
 <ns1:response>
  <ns1:responseStatus>SUCCESS</ns1:responseStatus>
  <ns1:targetResponse>
   <ns1:targetServiceIdentifier>STUDY_PROTOCOL</ns1:targetServiceIdentifier>
   <ns1:targetServiceOperation>getInterventionalStudyProtocol</ns1:targetServiceOperation>
   <ns1:targetMessageStatus>RESPONSE</ns1:targetMessageStatus>
   <ns1:targetBusinessMessage>
    <ns1:xmlSchemaDefinition>http://po.coppa.nci.nih.gov</ns1:xmlSchemaDefinition>
    <ns1:InterventionalStudyProtocol xmlns:ns1="http://pa.services.coppa.nci.nih.gov">
     <ns1:identifier extension="27565" identifierName="NCI study protocol entity identifier" root="2.16.840.1.113883.3.26.4.3"/>

     <ns1:acronym nullFlavor="NI"/>

     <ns1:accrualReportingMethodCode code="AE"/>

     <ns1:assignedIdentifier extension="NCI-2009-00004"/>

     <ns1:dataMonitoringCommitteeAppointedIndicator value="false"/>

     <ns1:delayedpostingIndicator nullFlavor="NI"/>

     <ns1:expandedAccessIndicator nullFlavor="NI"/>

     <ns1:fdaRegulatedIndicator value="true"/>

     <ns1:reviewBoardApprovalRequiredIndicator value="true"/>

     <ns1:officialTitle value="Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury"/>

     <ns1:phaseCode code="II"/>

     <ns1:phaseOtherText nullFlavor="NI"/>

     <ns1:primaryCompletionDate value="20091030000000.0000-0400"/>

     <ns1:primaryCompletionDateTypeCode code="Anticipated"/>

     <ns1:primaryPurposeCode code="Supportive Care"/>

     <ns1:primaryPurposeOtherText nullFlavor="NI"/>

     <ns1:publicDescription value="Patients must be recovered from the toxic effects of prior chemotherapy or radiation. Therapy may not start until at least 3 weeks since prior cytotoxic chemotherapy, two weeks from completion of radiation therapy, and one week for patients on tyrosine kinase inhibitors or other targeted therapy. No major surgery within 4 weeks, and minor procedures (mediport or needle biopsy) within 7 days"/>

     <ns1:publicTitle value="Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury"/>

     <ns1:recordVerificationDate value="20090904152455.0000-0400"/>

     <ns1:scientificDescription nullFlavor="NI"/>

     <ns1:section801Indicator value="false"/>

     <ns1:startDate value="20090925000000.0000-0400"/>

     <ns1:startDateTypeCode code="Anticipated"/>

     <ns1:keywordText nullFlavor="NI"/>

     <ns1:acceptHealthyVolunteersIndicator value="true"/>

     <ns1:studyProtocolType value="InterventionalStudyProtocol"/>

     <ns1:userLastCreated value="shahs2@mail.nih.gov"/>

     <ns1:statusCode code="Active"/>

     <ns1:statusDate value="20090904110308.0294-0400"/>

     <ns1:amendmentNumber nullFlavor="NI"/>

     <ns1:amendmentDate nullFlavor="NI"/>

     <ns1:amendmentReasonCode nullFlavor="NI"/>

     <ns1:submissionNumber value="1"/>

     <ns1:allocationCode code="Non-Randomized Trial"/>

     <ns1:blindedRoleCode nullFlavor="NI"/>

     <ns1:blindingSchemaCode code="Open"/>

     <ns1:designConfigurationCode code="Cross-over"/>

     <ns1:numberOfInterventionGroups value="1"/>

     <ns1:studyClassificationCode nullFlavor="NI"/>

</ns1:InterventionalStudyProtocol>
   </ns1:targetBusinessMessage>
  </ns1:targetResponse>
 </ns1:response>
</ns1:caXchangeResponseMessage>
